G-1 pretreatment of human melanoma cells inhibited tumor growth in mice and increased the innate and adaptative anti-tumor immune cells infiltration, such as NK and T CD8+ cells within the tumor, demonstrating a great potential of GPER agonist as a cancer immunotherapy adjuvant [135]. The gene discussed is CD8A; the disease is neoplasm.